Thesis

Street consensus, scenarios, merits, risks, and invalidation triggers

AI-assisted
Thesis Summary

Masco combines credible long-term objectives with mixed near-term operating evidence. Management targets 3%-4% average annual organic sales growth, at least an 18% adjusted operating margin, and approximately 10% adjusted EPS compound annual growth through 2028. However, second-quarter 2026 net sales declined 3%, and the reported profit acceleration included approximately $95 million of net IEEPA tariff refunds. Management raised 2026 adjusted EPS guidance to $4.40-$4.60, citing an anticipated full-year net refund benefit of approximately $85 million. Masco's investor-relations site displayed a $73.25 share price on retrieval.

Sign in / Sign up to read more
This section is the 12-month view: analyst targets and the probability-weighted scenarios built from them. The intrinsic value at the top of this page answers a different question: what the business is worth today.
Street view · analyst 12-month targets17 analysts · as of 18 Aug 2026
Low · most bearish analyst$68.00
Mean target$80.65
High · most bullish analyst$96.00
Street targets sit above today's price; our intrinsic value sits below it. Different horizons, different questions.
Our research · scenarios, merits, risks, and invalidation triggersResearch as of 2 Sep 2026
Scenarios · 12-month scenario targetsAnchored at research date
Bear CaseDownside scenario
$68.0024%

Sales contraction persists, tariff-refund benefits prove non-recurring or fall below expectations, and weak repair-and-remodel demand prevents Masco from reaching its organic-growth and margin objectives. The scenario price reference is Masco's investor-relations-displayed 52-week low.

Base CaseCentral scenario
$80.6557%
Matches the consensus mean

Underlying demand remains subdued but stabilizes, Masco delivers 2026 adjusted EPS within its $4.40-$4.60 guidance range, and execution toward the 2028 targets remains credible without a rapid housing-cycle recovery.

Bull CaseUpside scenario
$96.0019%

Masco restores organic sales growth, converts its brand and commercial investments into above-market gains, and delivers its 2028 objectives of 3%-4% average annual organic growth, at least an 18% adjusted operating margin, and approximately 10% adjusted EPS CAGR. The scenario price reference is Masco's investor-relations-displayed 52-week high.

Scenarios are anchored to street consensus at the research date, with our probabilities and rationale.

Key Investment Merits
  • Management has established measurable 2028 objectives: 3%-4% average annual organic sales growth, an adjusted operating margin of at least 18%, and approximately 10% adjusted EPS CAGR.
  • Masco increased 2026 adjusted EPS guidance to $4.40-$4.60 after reporting second-quarter adjusted EPS growth of 26% to $1.64.
Sign in / Sign up to read more
Key Investment Risks
  • Second-quarter 2026 net sales declined 3%, including declines of 3% in Plumbing Products and 4% in Decorative Architectural Products.
  • Second-quarter profitability included approximately $95 million of net IEEPA tariff refunds, while the guidance increase reflected an anticipated full-year net benefit of approximately $85 million; this limits the usefulness of headline margin and EPS growth as indicators of recurring performance.
Sign in / Sign up to read more

All scenarios are estimates and subject to change. Past performance is not indicative of future results.

Quality Pillars Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up

Explore this dossier

AI-assisted, source-linked narrative; figures from company filings (SEC EDGAR) and market data. Dates shown per section. Not investment advice. Terms of Use.